Showing results (1-10 of 9) with videos related to
Sort By:
Pageof 1
Cancer Cell|August 2, 2003
Getting oncolytic virus therapies off the groundJohn C Bell, Brian Lichty, David StojdlACS Omega|August 29, 2019
Codelivery of mRNA with α-Galactosylceramide Using a New Lipopolyplex Formulation Induces a Strong Antitumor Response upon Intravenous AdministrationMaria L Guevara, Zachary Jilesen, David Stojdl, et al.Journal of Virology|April 18, 2008
Vesicular stomatitis virus oncolysis of T lymphocytes requires cell cycle entry and translation initiationStephanie Oliere, Meztli Arguello, Thibault Mesplede, et al.Journal of Virology|March 21, 2014
Vesiculovirus neutralization by natural IgM and complementMulu Z Tesfay, Arun Ammayappan, Mark J Federspiel, et al.BMC Cancer|September 1, 2017
Spatial and temporal epithelial ovarian cancer cell heterogeneity impacts Maraba virus oncolytic potentialJessica G Tong, Yudith Ramos Valdes, Milani Sivapragasam, et al.The Journal of Clinical Investigation|November 14, 2018
Type I IFN blockade uncouples immunotherapy-induced antitumor immunity and autoimmune toxicityScott R Walsh, Donald Bastin, Lan Chen, et al.Molecular Therapy Oncolytics|April 28, 2016
Evidence for differential viral oncolytic efficacy in an in vitro model of epithelial ovarian cancer metastasisJessica G Tong, Yudith Ramos Valdes, John W Barrett, et al.Nature Communications|June 15, 2013
Model-based rational design of an oncolytic virus with improved therapeutic potentialFabrice Le Bœuf, Cory Batenchuk, Markus Vähä-Koskela, et al.Cancer Research|May 10, 2014
Re-engineering vesicular stomatitis virus to abrogate neurotoxicity, circumvent humoral immunity, and enhance oncolytic potencyAlexander Muik, Lawton J Stubbert, Roza Z Jahedi, et al.Pageof 1